Inmed Pharmaceuticals Inc.
INMCIK 0001728328 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Oct 24, 2025. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone 0.0012
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Inmed Pharmaceuticals Inc.
| Name | Roles | Filings |
|---|---|---|
| Johnson Shane Aaron | Officer | 4 |
| Baldasare Bryan T | Director | 3 |
| Grove Janet P | Director | 3 |
| Lemerond Nicole | Director | 3 |
| Jagpal Netta | Officer | 2 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Inmed Pharmaceuticals Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Adams Eric A | 3 | 0% | -37.3% | -47.7% | -13.3% | -51.0% |
All filings
68 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|